Abstract:To study further the molecular mechanisms by which glutamate and dopamine interact to regulate the functions of the basal ganglia, the effects of persistently inhibiting dopamine receptors and glutamate N-methyl-D-aspartate receptors on the density of D-1 and D-2 dopamine receptors and on the level of their transcripts were examined in mouse brain. To block dopamine receptors, mice were treated with N-ethoxycarbonyr-2-ethoxy-1,2-dihydroquinoline once daily for two and six days, or were treated with fluphenazine-N-mustard once daily for five days. To block N-methyl-D-aspartate receptors, mice were treated with dizocilpine by continuous infusion with osmotic mini-pumps for two and six days. The density of D-1 and D-2 dopamine receptors was measured by receptor autoradiography, and the lever of D-1 and D-2 dopamine receptor messenger RNA was measured by in situ hybridization histochemistry. The results showed that N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline blocked about 90% of both D-1 and D-2 dopamine receptors, but had no significant effect on the lever of either D-1 or D-2 dopamine receptor messenger RNA. Fluphenazine-N-mustard, which was as effective as N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in blocking D-2 dopamine receptors but had little effect on D-1 dopamine receptors, also had no significant effect on the level of D-1 and D-2 dopamine receptor messenger RNAs. By contrast, continuously infusing dizocilpine significantly decreased the levels of D-1 dopamine receptor messenger RNA in striatum, nucleus accumbens and olfactory tubercle. Dizocilpine also caused small decreases in the density of D-2 dopamine receptors, but only in posterior striatum was this decrease statistically significant. Dizocilpine slightly and transiently decreased the levels of D-1 dopamine receptor messenger RNA in striatum but had no significant effect on the density of D-1 dopamine receptors in any region examined.This study demonstrates that persistent blockade of D-1, and D-2 dopamine receptors has relatively little effect on the levels of D-1 and D-2 dopamine receptor messenger RNA, but that blockade of N-methyl-D-aspartate receptors produces a rapid and profound decrease in the levels of D-2 dopamine receptor messenger RNA and a smaller decrease in the density of D-2 dopamine receptors. These results suggest that N-methyl-D-aspartate receptors play an important role in the expression of D-2 dopamine receptors in basal ganglia.

Dopamine receptor blockade increases dopamine D2 receptor and glutamic acid decarboxylase mRNAs in mouse substantia nigra.

Dopamine-Receptor Blockade Increases Dopamine D-2 Receptor And Glutamic-Acid Decarboxylase Messenger-Rnas In Mouse Substantia-Nigra

D-2 Dopamine-Receptor Messenger-Rna Is Altered To A Greater Extent By Blockade Of Glutamate Receptors Than By Blockade Of Dopamine-Receptors

Dopaminergic and glutamatergic blocking drugs differentially regulate glutamic acid decarboxylase mRNA in mouse brain

Lesions Of Mouse Striatum Induced By 6-Hydroxydopamine Differentially Alter The Density, Rate Of Synthesis, And Level Of Gene-Expression Of D-1 And D-2 Dopamine-Receptors

Irreversible blockade of D2 dopamine receptors by fluphenazine-N-mustard increases D2 dopamine receptor mRNA and proenkephalin mRNA and decreases D1 dopamine receptor mRNA and mu and delta opioid receptors in rat striatum

Neuronal Localization and Modulation of the D2 Dopamine Receptor Mrna in Brain of Normal Mice and Mice Lesioned with 6-Hydroxydopamine

In Vivo Administration of an Oligodeoxynucleotide Antisense to the D2 Dopamine Receptor Messenger RNA Inhibits D2 Dopamine Receptor-Mediated Behavior and the Expression of D2 Dopamine Receptors in Mouse Striatum.

A comparison of D1 receptor binding and mRNA in rat brain using receptor autoradiographic and in situ hybridization techniques

Alterations in Dopamine Release but Not Dopamine Autoreceptor Function in Dopamine D3 Receptor Mutant Mice

L-DOPA Treatment Modulates Nicotinic Receptors in Monkey Striatum.

Knockout of Dopamine D3 Receptor Gene Blocked Methamphetamine-Induced Distinct Changes of Dopaminergic and Glutamatergic Synapse in the Nucleus Accumbens Shell of Mice

Dopamine D3 receptor mutant mice exhibit increased behavioral sensitivity to concurrent stimulation of D1 and D2 receptors.

Changes in surface expression of N-methyl-D-aspartate receptors in the striatum in a rat model of Parkinson's disease.

D2 Dopamine Receptor Antisense Oligodeoxynucleotide Inhibits the Synthesis of a Functional Pool of D2 Dopamine Receptors.

Role of Dopamine D3 Receptors in Methamphetamine-Induced Behavioural Sensitization and the Characterization of Dopamine Receptors (D1R–D5R) Gene Expression in the Brain

D2 Receptor-Mediated Mirna-143 Expression is Associated with the Effects of Antipsychotic Drugs on Phencyclidine-Induced Schizophrenia-Related Locomotor Hyperactivity and with Neuregulin-1 Expression in Mice.

Depletion of D3 Dopamine Receptor Affects Methamphetamine-Induced Expression Patterns of Pde4b and Atf3.

NMDA-evoked release of striatal neurotransmitters in vivo is differentially affected by low and high doses in neuronal nitric oxide synthase mutant mice

Distinct roles of dopamine D3 receptors in modulating methamphetamine-induced behavioral sensitization and ultrastructural plasticity in the shell of the nucleus accumbens.

Combinatorial topography and cell-type specific regulation of the ERK pathway by dopaminergic agonists in the mouse striatum